Golden
LoginSign Up
Azitra

Azitra

A company based in Farmington, Connecticut, that develops skin disease treatments using microbiome science and technology.

Azitra's platform uses a strain of the skin microbiome, S. epidermidis, to modify the skin microbiome and deliver therapeutic protein to the target. The platform is modular and can modify S. epidermidis to secrete an array of therapeutically relevant proteins necessary in the treatment of multiple skin diseases.

Azitra's work is supported by NIH grants, private grants, and investment from Bios Partners and Breakout labs.

In May 2018, Azitra announced that it had secured $2.15 million in convertible debt financing to support advancement of the company's pipeline of dermatology and skin care products. The financing was led by new investor Connecticut Innovations, and existing investor Bios Partners. An additional new investor, KdT Ventures, joined the syndicate. This financing brings the total raised to date to $5.4 million.

Timeline

Azitra secured $2.15m in convertible debt financing

Funding was led by Bios Partners and Connecticut Innovations

People

Name
Role
Related Golden topics

Richard Andrews

President and CEO

Thrasos Therapeutics

Travis Whitfill

Founder and CSO

Further reading

Title
Author
Link
Type

The Microbiome Movement: Commensal Cosmetics Offer a Viable Future

Travis Whitfill, Azitra Inc., Farmington, CT and Yale University School of Medicine, New Haven, CT USA

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References